Zvi Fuks
Zvi Fuks Elected to the Institute of Medicine

Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine.

Saturday, January 1, 2011
Pictured: Craig Thompson
Craig Thompson Named President of Memorial Sloan Kettering

Nationally known cancer researcher and clinician Craig B. Thompson was named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center in August 2010. He also becomes President of Gerstner Sloan Kettering Graduate School of Biomedical Sciences.

Wednesday, December 15, 2010
Summer Students' Research Recognized at National Conference

Three 2010 summer students won poster awards at the Annual Biomedical Research Conference for Minority Students in November.

Wednesday, December 1, 2010
Novel Genetic Mutation that Causes the Most Common form of Eye Cancer Discovered

An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more than 40 percent of tumor samples taken from patients with uveal melanoma.

Wednesday, November 17, 2010
Samuel Danishefsky
Memorial Sloan Kettering Enters Agreement to Develop New Cancer Drug

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.

Friday, October 1, 2010
Alexander Rudensky
An Interview With Alexander Rudensky

A member of the Sloan Kettering Institute’s Immunology Program and a Howard Hughes Medical Institute investigator, Alexander Rudensky is fascinated by how a specific type of white blood cells called regulatory T cells regulates our immune system.

Friday, October 1, 2010
Study Answers Important Question about Using Carbon Nanotubes in Medicine

A multicenter study led by Memorial Sloan Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.

Friday, October 1, 2010
Pictured: Eric C. Holland
Researchers Discover Genetic Changes That Make Some Forms of Brain Cancer More Aggressive Than Others

A multi-institutional team led by investigators from Memorial Sloan Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies.

Friday, October 1, 2010
2010 Shaps Scholars

Four summer students — Jeannie Camarillo, Emily Grzybowski, Nathaniel Kim, and Daniel Triner — were named 2010 Rubin and Sarah Shaps Scholars.

Wednesday, September 1, 2010
A Decade of Leadership

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.

Thursday, July 1, 2010